- ICH GCP
- US Clinical Trials Registry
- Forskere
- Tyskland
- Leukemi, hårcelle
Medisinske spesialister fra Tyskland merket som etterforskere i kliniske studier som studerer Leukemi, hårcelle
Totalt 76 resultater
-
Axel Matzdorff, Prof PhDSett i:
- Saarbrücken, Caritas Klinik St. Theresia
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Barbara Kempf, PhDSett i:
- Landshut, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Christian Buske, Prof PhDSett i:
- Ulm, University Clinic Ulm
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Christina Balser, PhDSett i:
- Marburg, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Clemens Müller-Naendrup, PhDSett i:
- Olpe, St. Martinus-Hospital
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Dietrich Kämpfe, PhDSett i:
- Lüdenscheid, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Dirk Strumberg, Prof PhDSett i:
- Herne, Marienkrankenhaus
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Eckhard Thiel, Prof PhDSett i:
- Berlin, Charité - Universitätsmedizin Berlin
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Eckhart Weidmann, Prof PhDSett i:
- Frankfurt, Krankenhaus Nordwest
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Ekkehart Ladda, PhDSett i:
- Neumarkt, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Else Heidemann, Prof. PhDSett i:
- Stuttgart, Diakonie - Klinikum Stuttgart
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Eva Huntenburg, PhDSett i:
- Landau, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
F A Trux, PhDSett i:
- Siegen, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Felix Marquard, PhDSett i:
- Celle, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Georg Ch Schließer, PhDSett i:
- Gießen, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Georg Heß, PhDSett i:
- Mainz, Universitatsklinik Mainz
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Georgi Kojouharoff, PhDSett i:
- Darmstadt, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Gerd Lautenschläger, PhDSett i:
- Hanau, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Gertrud Lenzen, PhDSett i:
- Osnabrück, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Guido Kobbe, PhDSett i:
- Düsseldorf, Universitätsklinik Düsseldorf
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
H W Lindemann, PhDSett i:
- Hagen, St.-Marien-Hospital
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
H Weiss, Prof PhDSett i:
- Ludwigshafen, St. Marienkrankenhaus
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Hans P Laubenstein, PhDSett i:
- Trier, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Harald Wagner, PhDSett i:
- Fürth, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Helmut Oettle, PhDSett i:
- Friedrichshafen, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Herbert Lebahn, PhDSett i:
- Berlin, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Joachim Haessner, PhDSett i:
- Wolfsburg, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Joachim Zimber, PhDSett i:
- Nürnberg, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Johann Mittermüller, PhDSett i:
- Germering, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser: -
Johannes Selbach, PhDSett i:
- Duisburg, Community based hemato-oncology medical office
Prøver:- NCT02131753 (Hovedetterforsker)
Betingelser:
Kliniske studier på Leukemi, hårcelle
-
MedImmune LLCAvsluttetB-Cell Pediatric ALLForente stater, Australia, Frankrike, Spania, Canada, Nederland, Storbritannia, Italia
-
National Cancer Institute (NCI)FullførtT-celle stor granulær lymfatisk leukemi | Leukemi, T-Cell Large Granular LymfocyttForente stater
-
Second Affiliated Hospital of Guangzhou Medical...Hunan Zhaotai Yongren Medical Innovation Co. Ltd.RekrutteringAnti-kreft celle immunterapi | T Cell og NK CellKina
-
University of SurreyAmerican Society of HematologyRekrutteringSkrøpelighet | Kronisk lymfatisk leukemi | Muskelfunksjon | Immunfunksjon | Lipid Cell; SvulstStorbritannia
-
SanofiRekrutteringMyelodysplastiske syndromer | Akutt lymfatisk leukemi | Akutt myeloid leukemi refraktær | Blastisk Plasmacytoid Dendritisk Cell NeoplasiaNederland, Frankrike, Forente stater, Australia, Kina
-
Peking University People's HospitalUkjentNatural Killer Cell Medited ImmunitetKina
-
Center for International Blood and Marrow Transplant...Cellular Dynamics International, Inc. - A FUJIFILM CompanyAvsluttetiPS Cell Manufacturing and Banking
-
Essen BiotechHar ikke rekruttert ennåT-celle lymfom | T-celle prolymfocytisk leukemi | T-celle akutt lymfatisk leukemi | T-celleleukemi | T-celle lymfom i CNS | T Cell Childhood ALLEKina
-
Medtronic - MITGAvsluttetEsophageal squamous cell neoplasia (ESCN)Kina
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)FullførtTilbakevendende Hodgkin-lymfom | Refraktært Hodgkin-lymfom | Tilbakevendende mantelcellelymfom | Refraktær kronisk lymfatisk leukemi | Refraktært mantelcellelymfom | Blastoid Variant Mantle Cell Lymfom | Tilbakevendende kronisk lymfatisk leukemi | Tilbakevendende follikulært lymfom | Refraktært follikulært...Forente stater